- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01626638
Confocal Micro-endoscopy in Head and Neck Cancer/Micro Endoscopie Confocale (MEC)Oto-Rhino-Laryngologie (ORL) (MEC ORL)
February 17, 2021 updated by: Gustave Roussy, Cancer Campus, Grand Paris
Clinical Evaluation of Confocal Microscopy in Head and Neck Cancer
The primary objective is to validate the diagnostic correlation between the intraoperative microendoscopic images and the conventional histological analysis on biopsy and/or surgical specimens on patients with epidermoid carcinoma.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Toulouse, France
- Institut Universitaire du Cancer de Toulouse - Oncopole
-
-
Val De Marne
-
Villejuif, Val De Marne, France, 94805
- Institut Gustave Roussy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with malignant and pre-malignant pharyngo laryngeal tumors in whom direct laryngoscopy was performed under general anesthesia with biopsies for diagnostic or endoscopic removal
- > 18 years
- signed ICF
Exclusion Criteria:
- Persons deprived of liberty
- Patients with history of allergy to patent blue
- Pregnant women or breastfeeding women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Diagnostic correlation between confocal micro endoscopy and conventional histology
Time Frame: at an average of 18 months
|
at an average of 18 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Histological diagnostic with confocal micro endoscopy (MEC) VS conventional histological analysis
Time Frame: At the time of the biopsy
|
At the time of the biopsy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Stéphane TEMAM, MD, Gustave Roussy, Cancer Campus, Grand Paris
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2013
Primary Completion (Actual)
May 24, 2017
Study Completion (Actual)
May 24, 2017
Study Registration Dates
First Submitted
June 15, 2012
First Submitted That Met QC Criteria
June 22, 2012
First Posted (Estimate)
June 25, 2012
Study Record Updates
Last Update Posted (Actual)
February 18, 2021
Last Update Submitted That Met QC Criteria
February 17, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011-A00818-33
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Pharyngo Laryngeal Tumors
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedMalignant Tumors | Refractory TumorsFrance
-
Peking Union Medical College HospitalPeking University; Peking University Cancer Hospital & InstituteRecruiting
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedMalignant TumorsJapan
-
InnoPharmax Inc.CompletedMalignant TumorsTaiwan, United States
-
Nanjing Leads Biolabs Co.,LtdRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingMalignant Solid TumorsUnited States
-
LaNova Medicines LimitedSuspendedMalignant TumorsChina
-
BayerRecruitingSolid Malignant TumorsTaiwan, Japan, Korea, Republic of, France, India, Spain
-
Hangzhou Sumgen Biotech Co., Ltd.Recruiting
-
NovaRock Biotherapeutics, LtdRecruitingAdvanced Malignant TumorsChina
Clinical Trials on Confocal Micro Endoscopy
-
King Chulalongkorn Memorial HospitalCompletedComplication of Diagnostic Procedure | Adverse Effect of Diagnostic Agents, Subsequent EncounterThailand
-
Yonsei UniversityCompletedGastric CancerKorea, Republic of
-
Johns Hopkins UniversityAmerican Society for Gastrointestinal Endoscopy; Pentax, USACompletedBarrett's Esophagus | Esophageal AdenocarcinomaUnited States
-
Shandong UniversityNational University Hospital, Singapore; Prince of Wales Hospital, Shatin,... and other collaboratorsUnknownGastric Carcinoma | Gastric Intestinal Metaplasia | Gastric Intraepithelial NeoplasiaSingapore, Australia, China
-
Mayo ClinicWithdrawn
-
University of AlbertaCompleted
-
Singapore General HospitalCompletedDiffuse Parenchymal Lung DiseasesSingapore
-
Medical University of ViennaCompleted
-
Medical University of ViennaUnknown
-
University of Medicine and Pharmacy CraiovaUnknownGastrointestinal Neoplasms | Gastric Cancer | Colorectal CancerRomania